HomeINDP • NASDAQ
Indaptus Therapeutics Inc
add
$2.57
6.20%
After Hours:(1.56%)-0.040
$2.53
Closed: Sep 18, 7:37:40 PM UTC-4 · USD · NASDAQ · Disclaimer
Market news
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 4.46M | 8.47% |
Net income | -5.23M | -30.23% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | -4.46M | -8.46% |
Effective tax rate | — | — |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 6.16M | -15.67% |
Total assets | 6.84M | -15.79% |
Total liabilities | 8.51M | 335.29% |
Total equity | -1.67M | — |
Shares outstanding | 1.11M | — |
Price to book | -0.87 | — |
Return on assets | -181.90% | — |
Return on capital | -288.55% | — |
Cash Flow
Net Change in Cash
Net change in cash
| (USD) | Jun 2025info | Y/Y change |
|---|---|---|
Net income | -5.23M | -30.23% |
Cash from operations | -4.02M | -62.16% |
Cash from investing | — | — |
Cash from financing | 6.28M | 16,411.32% |
Net change in cash | 2.27M | 192.90% |
Free cash flow | -2.37M | -129.59% |
Previous close
$2.42
Day range
$2.31 - $2.61
Year range
$2.22 - $58.24
Market cap
2.76M USD
Avg Volume
150.01K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2021
Website
Employees
7
